bold ideas that fuel dialogue to adapt and adopt to shifting paradigms

sabrina xo

if not now, when?

do we want an innovative canada or are we ok with a balanced-book kind of canada? if that isn’t the million dollar question these days. the proposed PMPRB regulations are in stark contrast to some of the initiatives in innovation and life sciences that some of the...

read more

car-t. one year later

on september 5.2018 health canada gave a notice of compliance [NOC] for tisagenlecleucel [kymriah]. it was the first chimeric antigen receptor [car] t-cell therapy to receive regulatory approval in canada. but here we are one year later after health canada’s approval...

read more

managing expectations

car t-cell therapy is the next big cancer treatment hitting the canadian cancer treatment landscape— with one recently approved car t-cell therapy and another on the way for use in specific patients with B-cell acute lymphoblastic leukemia [ALL] and large B-cell...

read more

how car-t is an opportunity for canada

the arrival of car t-cell therapy is disrupting the canadian healthcare system, but it has also offered an opportunity for canada to position itself as a leader in the delivery of car-t cell therapy - circa 6 months ago. the delays in actually providing access to...

read more